Switzerland· 61506002
Zolmitriptan Sandoz
A zolmitriptan product, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Zolmitriptan is registered in 16 of 19 countries.
Countries holding a registration under ATC N02CC03 (zolmitriptan), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Zolmitriptan · ATC N02CC03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of zolmitriptan costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.05 in France to $7.21 in Switzerland — a ×6.9 gap.
- Switzerland: $7.21 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Zolmitriptan · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$7.21
- IT Italy$2.58
- FR France$1.05
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- N02CC03
- ATC class
- Zolmitriptan
- Defined daily dose
- 2.5 mg, N
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- gtin76806150600216 StkCHF 35.6
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
114 interactions on record for zolmitriptan.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zolmitriptan · interactions on record
114 records
- 11 severe
- 25 moderate
- 5 minor
- 72 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N02CC03
Zolmitriptan, as other registers publish it.
- GermanyAscotopGrünenthal Gmbh
- GermanyAscotop NasalGrünenthal Gmbh
- CanadaAURO-ZOLMITRIPTANAURO PHARMA INC
- CanadaBIO-ZOLMITRIPTANBIOMED PHARMA
- ItalyHEADZOLLANOVA FARMACEUTICI S.R.L.
- CanadaJAMP-ZOLMITRIPTANJAMP PHARMA CORPORATION
- CanadaMINT-ZOLMITRIPTANMINT PHARMACEUTICALS INC
- CanadaNAT-ZOLMITRIPTANNATCO PHARMA (CANADA) INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdb78b41-64e5-456a-9009-76066e7e7a4e GET /v1/drugs/cdb78b41-64e5-456a-9009-76066e7e7a4e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "zolmitriptanum 2.5 mg",
"valid_from": "2013-01-01",
"limitations": null,
"galenic_form": "Filmtabl 2.5 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2013-01-01",
"self_retention_pct": 10
}See everything about zolmitriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.